Effects of Early Mobilization and Feeding After Lobectomy
The Effect of Early Nutrition and Mobilization From ERAS Protocols on Patient Outcomes in Lung Cancer Patients Undergoing Lobectomy
3 other identifiers
interventional
60
1 country
1
Brief Summary
This randomized controlled study evaluates the effects of early mobilization and early oral feeding, two components of the Enhanced Recovery After Surgery (ERAS) protocol, on postoperative outcomes in adult patients with lung cancer undergoing lobectomy at Ege University Hospital. Participants were randomly assigned to an intervention group or a control group. In addition to standard postoperative care, participants in the intervention group received an ERAS-based protocol consisting of sitting at the bedside approximately 5.5 hours after surgery, beginning mobilization at 6 hours, and walking at least 100 meters when clinically stable and approved by the surgical team. Oral water intake was started at 6 hours, followed by a full liquid diet at 7 hours and gradual transition to a regular diet at 12 hours if tolerated. Participants in the control group received the clinic's standard postoperative care. The study compares postoperative pain, complications, chest tube duration, length of hospital stay, reoperation, readmission within 30 days, nutritional status, laboratory findings, and quality of life between the two groups. Participants are followed for up to three months after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2026
CompletedFirst Submitted
Initial submission to the registry
August 3, 2026
CompletedFirst Posted
Study publicly available on registry
August 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 30, 2026
August 6, 2026
August 1, 2026
6 months
August 3, 2026
August 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Chest Tube Duration
The duration of chest tube placement is measured in days from the date of surgery until chest tube removal. The mean duration is compared between the experimental and control groups using hospital records.
From surgery until chest tube removal, anticipated up to 30 days
Postoperative Pain Intensity Assessed Using a Visual Analog Scale (VAS)
Pain intensity is assessed using a 100-mm Visual Analog Scale, where 0 mm indicates no pain and 100 mm indicates the worst imaginable pain. Higher scores indicate greater pain intensity. Scores are compared between the experimental and control groups at each assessment time point.
Postoperative days 1, 2, and 3; 7 days after discharge; and 1 month after discharge
Incidence and Severity of Postoperative Complications
The number and percentage of participants who develop one or more postoperative complications, including prolonged air leak lasting 7 days or more, atelectasis, pneumonia, chylothorax, atrial fibrillation, or postoperative bleeding. Complication severity is graded according to the Clavien-Dindo classification.
From surgery through 30 days after surgery
Length of Hospital Stay
Length of hospital stay is measured in days from the date of surgery until hospital discharge. The mean duration is compared between the experimental and control groups using hospital records.
From surgery until hospital discharge, anticipated up to 30 days
Secondary Outcomes (5)
All-Cause Hospital Readmission Within 30 Days After Discharge
Within 30 days after hospital discharge
Unplanned Reoperation Within 30 Days After Surgery
From surgery through 30 days after surgery
Change in Quality of Life Assessed Using the EORTC QLQ-C30
Preoperative baseline and 1 and 3 months after hospital discharge
Change in Lung Cancer-Specific Symptoms Assessed Using the EORTC QLQ-LC13
Preoperative baseline and 1 and 3 months after hospital discharge
Change in Nutritional Risk Assessed Using the NRS-2002
Preoperative baseline and 7 days after hospital discharge
Study Arms (2)
ERAS-Based Early Mobilization and Early Oral Feeding
EXPERIMENTALParticipants received the clinic's standard postoperative care plus an ERAS-based early mobilization and oral feeding protocol. When hemodynamically stable and with approval from the surgical team, participants sat at the bedside approximately 5.5 hours after surgery for 30 minutes, began mobilization at 6 hours, and walked at least 100 meters. Oral water intake began at 6 hours, followed by a full liquid diet at 7 hours and gradual transition to a regular diet at 12 hours if tolerated.
Standard Postoperative Care
ACTIVE COMPARATORParticipants received the clinic's standard postoperative care without the additional ERAS-based early mobilization and early oral feeding protocol. Routine care included postoperative monitoring, oxygen support as required, assessment of vital signs, drainage, respiratory function and pain, and coughing and breathing exercises. A liquid diet was initiated at 06:00 on the morning after surgery, and mobilization was performed according to the participant's hemodynamic condition and approval from the surgical team.
Interventions
Participants who were hemodynamically stable and approved by the surgical team were seated at the bedside approximately 5.5 hours after surgery for 30 minutes. The first mobilization began at postoperative hour 6, during which participants walked at least 100 meters with appropriate assistance.
For participants who were hemodynamically stable and approved by the surgical team, oral water intake was initiated at postoperative hour 6. If no intolerance occurred, a full liquid diet was started at hour 7, followed by a gradual transition to a regular diet at hour 12.
Participants received the clinic's routine postoperative care following lobectomy.
Eligibility Criteria
You may qualify if:
- Age 18 years or older
- Diagnosis or suspected diagnosis of lung cancer
- Scheduled to undergo lobectomy
- Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
- Voluntary agreement to participate and ability to provide informed consent
You may not qualify if:
- Requirement for emergency surgery
- Metastatic disease
- Severe uncontrolled comorbid disease, including cardiac, renal, or hepatic failure
- Requirement for mechanical ventilation for 24 hours or longer
- History of cranial trauma
- Requirement for prolonged bed rest
- Local peripheral neuropathy or central nervous system disease
- Cognitive or communication impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ege Universitylead
Study Sites (1)
Ege University Hospital, Department of Thoracic Surgery
Izmir, 35100, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MSc, RN
Study Record Dates
First Submitted
August 3, 2026
First Posted
August 6, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
October 30, 2026
Study Completion (Estimated)
October 30, 2026
Last Updated
August 6, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share